Senior insider sale
Chief Commercial Officer at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$474.7K
13.23K shares
What this filing means
HEERMA PETER plans to sell 13.23K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $474.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/29/2025ACC: 0001959173-25-007920
Officer· Chief Commercial Officer
Since Oct 2019
13.23K
Shares to sell
$474.7K
Approx. market value
4.98K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Restricted Stock Vesting
Compensation
1/21/2022
1.88KRestricted Stock Vesting
Compensation
2/4/2021
3.10KTotal acquired4.98K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/21/2022 | Restricted Stock Vesting Compensation | 1.88K | — |
2/4/2021 | Restricted Stock Vesting Compensation | 3.10K | — |
| Total | 4.98K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
5.59K
Market value
$195.7K
10/31/2025
—Completed
Units to sell
2.66K
Market value
$79.9K
10/28/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.98K
Market value
$199.2K
12/24/2025
Total
Units
13.23K
Value
$474.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/31/2025 | 5.59K | $195.7K | — | Completed |
10/28/2025 | 2.66K | $79.9K | — | Completed |
| Planned — Approximate Date | ||||
12/24/2025 | 4.98K | $199.2K | NASDAQ | Planned |
| Total | 13.23K | $474.7K | ||